- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | INIFY Laboratories AB: Inify Laboratories - More diagnoses delivered in the first quarter than in the whole of 2023 | 1 | Oslo Børs | ||
| 05.03. | INIFY LABORATORIES AB: Panel talk about Inify's fourth quarter 2023 | 1 | Cision News | ||
| 29.02. | INIFY Laboratories AB: Foresees a noticeable increase of customers, volume, and sales in 2024 | 1 | Oslo Børs | ||
| 07.12.23 | INIFY Laboratories AB: Financial calendar | 1 | Oslo Børs | ||
| 06.11.23 | INIFY LABORATORIES AB: Inify Laboratories receives accreditation as a medical laboratory | 2 | Cision News |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 52,05 | 0,00 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 32,540 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| ADAPTHEALTH | 10,130 | 0,00 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| ATRICURE | 23,370 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
| RXSIGHT | 53,26 | 0,00 % | RxSight, Inc. - 8-K, Current Report | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 24,300 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,44 | -0,57 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
| FRESENIUS | 27,980 | +1,08 % | DAX-Check LIVE: Airbus, Bayer, Deutsche Bank, Fresenius, Infineon, SAP im Fokus | Der DAX ist gestern erfolgreich in die neue Woche gestartet. Er legte um 0,6 Prozent zu und schloss damit bei 17.737 Punkten. Das Tageshoch lag sogar bei 17.889 Zählern. Worauf es jetzt für den DAX... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 10,910 | 0,00 % | BrightSpring Health Services appoints Timothy Wick to its board of directors | ||
| MIMEDX | 6,260 | 0,00 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
| FRESENIUS MEDICAL CARE | 39,030 | +0,98 % | Fresenius Medical Care: Was war das denn gestern? | Mit einem Kursanstieg um satte 6,44 Prozent wurde Fresenius Medical Care am Montag klarer Tagessieger im MDAX. Aber was war da los, was trieb die Aktie so stark? Vorab-Ergebnisse zum ersten Quartal... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,650 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,260 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2023 Results | SCOTTSDALE, Ariz., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| LIFEMD | 11,870 | 0,00 % | LifeMD, Inc.: LifeMD Appoints Dr. Calum MacRae to its Board of Directors | ||
| ALIGNMENT HEALTHCARE | 5,080 | 0,00 % | Demystifying Alignment Healthcare: Insights From 4 Analyst Reviews |
INIFY LABORATORIES AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -7,69 % bei einem Aktienkurs von 0,600 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
